Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,801 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia

NCT01518517

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Hopital Des Enfants Reine Fabiola Brussels, Belgium
  • Chr de La Citadelle Liège, Belgium
  • Chu D'Angers Angers, France
  • Hopital Saint Jacques Besançon, France
View all 28 locations
View Trial Details
Completed

Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)

NCT01724879

Conditions
Chromosome Aberrations, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Robert Bosch Krankenhaus Stuttgart, Baden-Wurttemberg, Germany
  • Klinikum der Universität Regensburg Regensburg, Bavaria, Germany
  • University Hospital of Frankfurt, Medical Dept. II Frankfurt am Main, Hesse, Germany
  • Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
View all 22 locations
View Trial Details
Completed

Double Cord Versus Haploidentical (BMT CTN 1101)

NCT01597778

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +30 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.

NCT01641107

Conditions
Acute Lymphoblastic Leukemia, BCR-ABL Positive, Hematologic Diseases, +11 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy
  • Az.Ospedaliera S.G.Moscati Avellino, Italy
View all 42 locations
View Trial Details
Completed

Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

NCT02120157

Conditions
Bone Marrow Diseases, Graft Survival, HLA-mismatched Bone Marrow Transplantation, +17 more
Locations
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Nemours Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States
  • All Children's Hospital Johns Hopkins Medicine St. Petersburg, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details

Related conditions